MoonLake Immunotherapeutics Ownership | Who Owns MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics Ownership Summary
MoonLake Immunotherapeutics is owned by 1.35% institutional investors, 10.85% insiders, and 87.80% retail investors. Bvf inc/il is the largest institutional shareholder, holding 31.21% of MLTX shares. Jupiter Merian Glb Eq AbsRet I USD Acc is the top mutual fund, with 1.65% of its assets in MoonLake Immunotherapeutics shares.
MLTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | MoonLake Immunotherapeutics | 1.35% | 10.85% | 87.80% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bvf inc/il | 19.75M | 31.21% | $141.62M |
| Avoro capital advisors | 2.00M | 3.16% | $14.34M |
| Cormorant asset management, lp | 1.99M | 3.15% | $14.30M |
| Jane street group | 1.68M | 2.65% | $22.17M |
| Adage capital partners gp | 1.50M | 2.37% | $10.76M |
| Morgan stanley | 1.04M | 1.65% | $13.77M |
| Schonfeld strategic advisors | 965.40K | 1.53% | $6.92M |
| Jpmorgan chase | 837.74K | 1.32% | $11.04M |
| Price t rowe associates inc /md/ | 822.96K | 1.30% | $5.90M |
| Fmr | 726.93K | 1.15% | $5.21M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bvf inc/il | 19.75M | 5.74% | $141.62M |
| Ghost tree capital | 300.00K | 4.13% | $13.19M |
| Lion point capital, lp | 67.50K | 2.75% | $483.98K |
| Cormorant asset management, lp | 1.99M | 0.99% | $14.30M |
| Boxer capital management | 250.00K | 0.57% | $1.79M |
| Eagle health investments lp | 187.60K | 0.54% | $2.47M |
| Rhenman & partners asset management ab | 364.00K | 0.45% | $4.80M |
| Ikarian capital | 435.84K | 0.32% | $3.12M |
| First turn management | 262.64K | 0.28% | $1.88M |
| Caitong asset management | 7.09K | 0.26% | $93.51K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | 1.68M | 0.00% | 1.66M |
| Adage capital partners gp | 1.50M | 0.02% | 1.50M |
| Schonfeld strategic advisors | 965.40K | 0.04% | 965.40K |
| Morgan stanley | 1.04M | 0.00% | 787.93K |
| Jpmorgan chase | 837.74K | 0.00% | 663.58K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | 1.99M | 0.99% | -6.50M |
| Fmr | 726.93K | 0.00% | -5.00M |
| Avoro capital advisors | 2.00M | 0.19% | -2.15M |
| Price t rowe associates inc /md/ | 822.96K | 0.00% | -1.79M |
| Westfield capital management co lp | - | - | -1.26M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Adage capital partners gp | 1.50M | 0.02% | 1.50M | $10.76M |
| Ikarian capital | 435.84K | 0.32% | 435.84K | $3.12M |
| Soleus capital management | 400.00K | 0.19% | 400.00K | $5.27M |
| Boothbay fund management | 258.78K | 0.03% | 258.78K | $1.86M |
| Boxer capital management | 250.00K | 0.57% | 250.00K | $1.79M |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -2.00 |
| True wealth design | -5.00 |
| Gamma investing | -6.00 |
| Montag a & associates | -7.00 |
| Creative financial designs inc /adv | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 17 | -90.17% | 854,269 | -97.72% | 1 | 0.04% | 13 | -85.71% | 3 | -93.33% |
| Sep 30, 2025 | 30 | -79.31% | 901,952 | -98.46% | 1 | 0.02% | 17 | -73.02% | 9 | -83.64% |
| Jun 30, 2025 | 145 | -2.03% | 58,588,368 | -0.85% | 92 | 1.06% | 63 | -11.27% | 54 | 25.58% |
| Mar 31, 2025 | 150 | 19.05% | 59,722,976 | -5.57% | 94 | 0.93% | 72 | - | 43 | 43.33% |
| Dec 31, 2024 | 124 | 6.90% | 63,224,599 | 1.80% | 100 | 1.03% | 70 | - | 30 | 20.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Jupiter Merian Glb Eq AbsRet I USD Acc | 1.18M | 1.65% | 1.18M |
| Polar Capital Biotech S Inc | 1.00M | 1.58% | - |
| Fidelity Growth Compy Commingled Pl S | 981.02K | 1.54% | 273.63K |
| Fidelity Growth Company Fund | 740.92K | 1.17% | 248.13K |
| Federated Hermes Kaufmann R | 665.00K | 1.05% | - |
| Federated Hermes Kaufmann Growth | 665.00K | 1.05% | - |
| T. Rowe Price Health Sciences | 742.02K | 1.03% | -58.25K |
| US Small-Cap Growth II Equity Comp | 523.89K | 0.83% | -134.19K |
| Fidelity Select Health Care | 520.00K | 0.82% | -150.00K |
| Federated Hermes Kaufmann Small Cap A | 503.00K | 0.79% | -16.00K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 08, 2025 | Santos da Silva Jorge | Chief Executive Officer | Sell | $1.96M |
| Dec 09, 2025 | Santos da Silva Jorge | Chief Executive Officer | Sell | $1.01M |
| Dec 08, 2025 | Reich Kristian | Chief Scientific Officer | Sell | $1.96M |
| Dec 09, 2025 | Reich Kristian | Chief Scientific Officer | Sell | $1.05M |
| Oct 08, 2025 | Bodenstedt Matthias | Chief Financial Officer | Buy | $98.81K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | 1 | 4 |
| 2025 Q3 | - | 6 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
MLTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools